Ftse Mib
34.460,52
0,00%
DAX
18.682,11
0,00%
S&P 500
5.307,01
-0,27%
NASDAQ
16.801,54
-0,18%
Bitcoin
69.497,72
0,57%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TenX Keane Acquisition (TENKU) TenX Keane Acquisition (TENKU) Notizie

TENKU

TenX Keane Acquisition (TENKU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TENKU
DataOraFonteTitoloSimboloCompagnia
21/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
20/05/202423:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
15/05/202422:24Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TENKUTenX Keane Acquisition
30/01/202423:25Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TENKUTenX Keane Acquisition
10/01/202421:21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TENKUTenX Keane Acquisition
10/01/202420:29GlobeNewswire Inc.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalNASDAQ:TENKUTenX Keane Acquisition
08/01/202422:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TENKUTenX Keane Acquisition
28/12/202318:39Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TENKUTenX Keane Acquisition
24/10/202313:42Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TENKUTenX Keane Acquisition
24/10/202313:30PR Newswire (US)Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
18/10/202322:00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
15/05/202322:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TENKUTenX Keane Acquisition
31/03/202322:33Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TENKUTenX Keane Acquisition
14/02/202321:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
10/02/202322:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TENKUTenX Keane Acquisition
06/12/202223:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
06/12/202222:58GlobeNewswire Inc.TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022NASDAQ:TENKUTenX Keane Acquisition
18/10/202220:20GlobeNewswire Inc.TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment OptionNASDAQ:TENKUTenX Keane Acquisition
14/10/202200:00GlobeNewswire Inc.TenX Keane Acquisition Announces Pricing of $60 Million Initial Public OfferingNASDAQ:TENKUTenX Keane Acquisition
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TENKU

La tua Cronologia

TSX
INE.DB.C
Innergex Renewable Energy
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network